167 related articles for article (PubMed ID: 37568977)
1. [
Filippi L; Urso L; Schillaci O; Evangelista L
Diagnostics (Basel); 2023 Aug; 13(15):. PubMed ID: 37568977
[TBL] [Abstract][Full Text] [Related]
2. Serial [
Boers J; Venema CM; de Vries EFJ; Hospers GAP; Boersma HH; Rikhof B; Dorbritz C; Glaudemans AWJM; Schröder CP
Eur J Cancer; 2021 Feb; 144():151-161. PubMed ID: 33341447
[TBL] [Abstract][Full Text] [Related]
3. Imaging Androgen Receptors in Breast Cancer with
Jacene H; Liu M; Cheng SC; Abbott A; Dubey S; McCall K; Young D; Johnston M; Van den Abbeele AD; Overmoyer B
J Nucl Med; 2022 Jan; 63(1):22-28. PubMed ID: 34049982
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Evaluation of
Antunes IF; Dost RJ; Hoving HD; van Waarde A; Dierckx RAJO; Samplonius DF; Helfrich W; Elsinga PH; de Vries EFJ; de Jong IJ
J Nucl Med; 2021 Aug; 62(8):1140-1145. PubMed ID: 33517325
[TBL] [Abstract][Full Text] [Related]
5. Androgen and Estrogen Receptor Imaging in Metastatic Breast Cancer Patients as a Surrogate for Tissue Biopsies.
Venema CM; Mammatas LH; Schröder CP; van Kruchten M; Apollonio G; Glaudemans AWJM; Bongaerts AHH; Hoekstra OS; Verheul HMW; Boven E; van der Vegt B; de Vries EFJ; de Vries EGE; Boellaard R; Menke van der Houven van Oordt CW; Hospers GAP
J Nucl Med; 2017 Dec; 58(12):1906-1912. PubMed ID: 28912144
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Simplified Methods for Quantification of
Kramer GM; Yaqub M; Vargas HA; Schuit RC; Windhorst AD; van den Eertwegh AJM; van der Veldt AAM; Bergman AM; Burnazi EM; Lewis JS; Chua S; Staton KD; Beattie BJ; Humm JL; Davis ID; Weickhardt AJ; Scott AM; Morris MJ; Hoekstra OS; Lammertsma AA
J Nucl Med; 2019 Sep; 60(9):1221-1227. PubMed ID: 30850488
[No Abstract] [Full Text] [Related]
7. Specific
Larimer BM; Dubois F; Bloch E; Nesti S; Placzek M; Zadra G; Hooker JM; Loda M; Mahmood U
J Nucl Med; 2018 Oct; 59(10):1538-1543. PubMed ID: 29853654
[TBL] [Abstract][Full Text] [Related]
8. Report on the PET/CT Image-Based Radiation Dosimetry of [
McCall KC; Liu M; Cheng SC; Abbott A; Dubey S; Young D; Johnston M; Van den Abbeele AD; Overmoyer B; Jacene H
J Nucl Med Technol; 2023 Sep; 51(3):204-210. PubMed ID: 37316304
[TBL] [Abstract][Full Text] [Related]
9. Consecutive Prostate-Specific Membrane Antigen (PSMA) and Antigen Receptor (AR) PET Imaging Shows Positive Correlation with AR and PSMA Protein Expression in Primary Hormone-Naïve Prostate Cancer.
Al Jalali V; Wasinger G; Rasul S; Grubmüller B; Wulkersdorfer B; Balber T; Mitterhauser M; Simon J; Hacker M; Shariat S; Egger G; Zeitlinger M
J Nucl Med; 2023 Jun; 64(6):863-868. PubMed ID: 36657982
[TBL] [Abstract][Full Text] [Related]
10. Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate Cancer.
Fox JJ; Gavane SC; Blanc-Autran E; Nehmeh S; Gönen M; Beattie B; Vargas HA; Schöder H; Humm JL; Fine SW; Lewis JS; Solomon SB; Osborne JR; Veach D; Sawyers CL; Weber WA; Scher HI; Morris MJ; Larson SM
JAMA Oncol; 2018 Feb; 4(2):217-224. PubMed ID: 29121144
[TBL] [Abstract][Full Text] [Related]
11. In vivo imaging of brain androgen receptors in rats: a [(18)F]FDHT PET study.
Khayum MA; Doorduin J; Antunes IF; Kwizera C; Zijlma R; den Boer JA; Dierckx RA; de Vries EF
Nucl Med Biol; 2015 Jun; 42(6):561-9. PubMed ID: 25735222
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic assessment of the uptake of 16beta-18F-fluoro-5alpha-dihydrotestosterone (FDHT) in prostate tumors as measured by PET.
Beattie BJ; Smith-Jones PM; Jhanwar YS; Schöder H; Schmidtlein CR; Morris MJ; Zanzonico P; Squire O; Meirelles GS; Finn R; Namavari M; Cai S; Scher HI; Larson SM; Humm JL
J Nucl Med; 2010 Feb; 51(2):183-92. PubMed ID: 20080885
[TBL] [Abstract][Full Text] [Related]
13. [
Orevi M; Shamni O; Zalcman N; Chicheportiche A; Mordechai A; Moscovici S; Shoshan Y; Shahar T; Charbit H; Gutreiman M; Paldor I; Mishani E; Lossos A; Lavon I
Neurooncol Adv; 2021; 3(1):vdab019. PubMed ID: 33738450
[TBL] [Abstract][Full Text] [Related]
14. Tumor localization of 16beta-18F-fluoro-5alpha-dihydrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancer.
Larson SM; Morris M; Gunther I; Beattie B; Humm JL; Akhurst TA; Finn RD; Erdi Y; Pentlow K; Dyke J; Squire O; Bornmann W; McCarthy T; Welch M; Scher H
J Nucl Med; 2004 Mar; 45(3):366-73. PubMed ID: 15001675
[TBL] [Abstract][Full Text] [Related]
15. Current applications of PET imaging of sex hormone receptors with a fluorinated analogue of estradiol or of testosterone.
Talbot JN; Gligorov J; Nataf V; Montravers F; Huchet V; Michaud L; Ohnona J; Balogova S; Cussenot O; Daraï E; Lotz JP; Kerrou K
Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):4-17. PubMed ID: 25693420
[TBL] [Abstract][Full Text] [Related]
16. Reproducibility and Repeatability of Semiquantitative
Vargas HA; Kramer GM; Scott AM; Weickhardt A; Meier AA; Parada N; Beattie BJ; Humm JL; Staton KD; Zanzonico PB; Lyashchenko SK; Lewis JS; Yaqub M; Sosa RE; van den Eertwegh AJ; Davis ID; Ackermann U; Pathmaraj K; Schuit RC; Windhorst AD; Chua S; Weber WA; Larson SM; Scher HI; Lammertsma AA; Hoekstra OS; Morris MJ
J Nucl Med; 2018 Oct; 59(10):1516-1523. PubMed ID: 29626121
[No Abstract] [Full Text] [Related]
17. Positron tomographic assessment of androgen receptors in prostatic carcinoma.
Dehdashti F; Picus J; Michalski JM; Dence CS; Siegel BA; Katzenellenbogen JA; Welch MJ
Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):344-50. PubMed ID: 15726353
[TBL] [Abstract][Full Text] [Related]
18. Visual and quantitative evaluation of [
Mammatas LH; Venema CM; Schröder CP; de Vet HCW; van Kruchten M; Glaudemans AWJM; Yaqub MM; Verheul HMW; Boven E; van der Vegt B; de Vries EFJ; de Vries EGE; Hoekstra OS; Hospers GAP; der Houven van Oordt CWM
EJNMMI Res; 2020 Apr; 10(1):40. PubMed ID: 32307594
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity of
Cysouw MCF; Kramer GM; Heijtel D; Schuit RC; Morris MJ; van den Eertwegh AJM; Voortman J; Hoekstra OS; Oprea-Lager DE; Boellaard R
EJNMMI Res; 2019 Jul; 9(1):70. PubMed ID: 31363939
[TBL] [Abstract][Full Text] [Related]
20. PET Imaging Agents (FES, FFNP, and FDHT) for Estrogen, Androgen, and Progesterone Receptors to Improve Management of Breast and Prostate Cancers by Functional Imaging.
Katzenellenbogen JA
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32718075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
